Search Results 381-390 of 90858 for Metastasis

  1. A Study of the Safety, Tolerability, Drug/Body Interactions, Biological and Clinical Activity of MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors

    A Study of the Safety, Tolerability, Drug/Body Interactions, Biological and Clinical Activity of MSB0011359C (M7824) in Metastatic or Locally Advanced Solid ...

  2. Rectal Cancer Clinical Trials - Mayo Clinic Research

    ... metastatic colorectal cancer. This study will also explore the accuracy of prediction of pre-existing and newly induced CD8+ T cell responses in each ...

  3. BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma - Mayo Clinic

    The purpose of this study is to determine whether BNC105P in combination with/following everolimus is effective in the treatment of progressive metastatic clear ...

  4. Transformative advances in bladder cancer treatment - Mayo Clinic

    ... metastatic urothelial bladder cancer. This combination, previously reserved for patients ineligible for cisplatin-based chemotherapy, has now become the ...

  5. Advanced therapies and innovative options for prostate cancer care - Mayo Clinic

    "The approaches to metastatic and localized prostate cancers are vastly different," says Dr. Childs. "The prognoses vary greatly, and treatment options can ...

  6. Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer - Mayo Clinic

    This phase II study will test cancer to see if it has a HER2 mutation and, if so, see how HER2 mutated cancer responds to treatment with neratinib.

  7. A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer - Mayo Clinic

    ... (metastatic). In this study, all participants will get either tucatinib ... Symptomatic brain metastasis. Progression of brain metastases since starting ...

  8. Sarcoma - Symptoms and causes - Mayo Clinic

    When cancer spreads, it's called metastatic cancer. Risk factors. Factors that can increase the risk of sarcoma include: Inherited syndromes. Some syndromes ...

  9. A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid Tumors that cannot be Removed by Surgery - Mayo Clinic

    A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid ...

  10. Nasopharyngeal carcinoma - Symptoms and causes - Mayo Clinic

    In time, cancer cells can break away and spread to other parts of the body. When cancer spreads, it's called metastatic cancer. Risk factors. Researchers have ...